ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

1TM Mithra Pharmaceuticals SA

0.216
0.00 (0.00%)
19:00:00 - Datos en tiempo real
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mithra Pharmaceuticals SA 1TM Tradegate Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.216 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.216
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/3/202400:00GLOBEMithra reports full year 2023 financial results
05/3/202400:01GLOBEMithra announces changes to its executive management
05/3/202400:00GLOBEMithra initiates monetization process, receives bridge loan..
29/2/202404:42GLOBEDONESTA® safety study for menopause completes treatment..
15/2/202411:23GLOBEMithra sells shares in Mayne Pharma
06/2/202400:00GLOBEMithra updates on cash position
21/12/202310:45GLOBEMithra and Rafa Laboratories sign binding Head of Terms to..
20/12/202310:45GLOBEMithra Completes Pediatric Study of ESTELLE® in Adolescent..
18/12/202300:00GLOBEMithra Receives Positive DSMB Opinion on DONESTA® European..
04/12/202300:00GLOBEMithra and Gedeon Richter sign binding Head of Terms to..
30/11/202300:00GLOBEMithra receives guidance from the FDA for the DONESTA® NDA..
28/11/202310:45GLOBEMithra to hold five presentations on key role of estrogens..
07/11/202300:00GLOBEMithra’s NEXTSTELLIS® granted additional patent in the..
06/11/202311:52GLOBEMithra releases invitation to its extraordinary securities..
26/10/202300:00GLOBEMithra and Searchlight Pharma sign DONESTA® licensing..
23/10/202300:00GLOBEMithra to receive EUR 2.5 million milestone payment from..
17/10/202300:00GLOBEMithra’s Board of Directors to propose the removal of its..
11/10/202300:15GLOBEShareholder Letter
11/10/202300:00GLOBEMithra announces update to the agenda of its upcoming..
10/10/202311:00GLOBEMithra to Hold Presentations on Key Role of Estrogens in..
05/10/202300:00GLOBEMithra Provides an Update in the Context of Recent Market..
27/9/202300:00GLOBEMithra Announces Presentation of Positive Data on Estetrol..
26/9/202300:00GLOBEMithra Financial Results for First-Half 2023
22/9/202306:30GLOBEMithra présentera ses résultats financiers du premier..
21/9/202310:55GLOBEInformation on the total number of voting rights..
12/9/202310:45GLOBEPublication of a Transparency Notification Received from..
11/9/202300:30GLOBELetter to Shareholders and Corporate Update

Su Consulta Reciente

Delayed Upgrade Clock